300
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Expression of Stem Cell Markers, CD133 and CD44, in Pediatric Solid Tumors: A Study Using Tissue Microarray

, , , , &
Pages 192-204 | Published online: 25 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Monica Cantile, Francesca Collina, Giosuè Scognamiglio, Maurizio Di Bonito, Renato Franco & Gerardo Botti. (2013) Inadequacy of tissue microarrays for the immunohistochemical detection of cancer stem cells in solid tumors: a viewpoint. Expert Review of Anticancer Therapy 13:10, pages 1139-1141.
Read now

Articles from other publishers (29)

Kyle A. Rohrer, Heyu Song, Anum Akbar, Yingling Chen, Suravi Pramanik, Phillip J. Wilder, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Angie Rizzino, Don W. Coulter & Sutapa Ray. (2023) STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo. Cancers 15:8, pages 2239.
Crossref
Shashikant Singh, Minakshi Bhardwaj, Amita Sen, Kaniyappan Nambiyar & Arvind Ahuja. (2022) Cancer Stem Cell Markers — CD133 and CD44 — in Paediatric Solid Tumours: A Study of Immunophenotypic Expression and Correlation with Clinicopathological Parameters. Indian Journal of Surgical Oncology 14:1, pages 113-121.
Crossref
Riccardo Di Fiore, Sherif Suleiman & Jean Calleja-Agius. 2023.
Roshna Lawrence Gomez, Shakhzada Ibragimova, Revathy Ramachandran, Anna Philpott & Fahad R. Ali. (2022) Tumoral heterogeneity in neuroblastoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:6, pages 188805.
Crossref
Andrzej Nowicki, Magdalena Kulus, Maria Wieczorkiewicz, Wojciech Pieńkowski, Katarzyna Stefańska, Paulina Skupin-Mrugalska, Rut Bryl, Paul Mozdziak, Bartosz Kempisty & Hanna Piotrowska-Kempisty. (2021) Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology. Cancers 13:16, pages 4178.
Crossref
Ehsan Aali, Zahra Madjd, Neda Tekiyehmaroof & Ali Mohammad Sharifi. (2020) Control of Hyperglycemia Using Differentiated and Undifferentiated Mesenchymal Stem Cells in Rats with Type 1 Diabetes. Cells Tissues Organs 209:1, pages 13-25.
Crossref
Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad & Mohammad Reza Abbaszadegan. (2019) Ovarian cancer stem cells and targeted therapy. Journal of Ovarian Research 12:1.
Crossref
Maryam Mansoori, Raheleh Roudi, Ata Abbasi, Maryam Abolhasani, Isa Abdi Rad, A. Shariftabrizi & Zahra Madjd. (2019) High GD2 expression defines breast cancer cells with enhanced invasiveness. Experimental and Molecular Pathology 109, pages 25-35.
Crossref
Somayeh Shafiei, Elham Kalantari, Leili Saeednejad Zanjani, Maryam Abolhasani, Mohammad Hossein Asadi Lari & Zahra Madjd. (2019) Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas. Experimental and Molecular Pathology 108, pages 164-172.
Crossref
Hisham F. Bahmad, Farah Chamaa, Sahar Assi, Reda M. Chalhoub, Tamara Abou-Antoun & Wassim Abou-Kheir. (2019) Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier. Frontiers in Molecular Neuroscience 12.
Crossref
Irina V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Sergey M. Deyev & Roman V. Kholodenko. (2018) Neuroblastoma Origin and Therapeutic Targets for Immunotherapy. Journal of Immunology Research 2018, pages 1-25.
Crossref
Sutapa Ray, Don W. Coulter, Shawn D. Gray, Jason A. Sughroue, Shrabasti Roychoudhury, Erin M. McIntyre, Nagendra K. Chaturvedi, Kishor K. Bhakat, Shantaram S. Joshi, Timothy R. McGuire & John G. Sharp. (2018) Suppression of STAT3 NH 2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21 . Molecular Carcinogenesis 57:4, pages 536-548.
Crossref
Elham Kalantari, Mohammad Hossein Asadi Lari, Raheleh Roudi, Alireza Korourian & Zahra Madjd. (2017) Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas. Cancer Biomarkers 20:4, pages 563-573.
Crossref
Raheleh Roudi, Marzieh Ebrahimi, Ahmad Shariftabrizi & Zahra Madjd. (2017) Cancer stem cell research in Iran: potentials and challenges. Future Oncology 13:20, pages 1809-1826.
Crossref
Elham Kalantari, Mojgan Asgari, Seyedehmoozhan Nikpanah, Naghme Salarieh, Mohammad Hossein Asadi Lari & Zahra Madjd. (2017) Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas. Pathology & Oncology Research.
Crossref
Zahra Madjd, Elham Erfani, Elmira Gheytanchi, Maziar Moradi-Lakeh, Ahmad Shariftabrizi & Mohsen Asadi-Lari. (2016) Expression of CD133 Cancer Stem Cell Marker in Melanoma: A Systematic Review and Meta-Analysis. The International Journal of Biological Markers 31:2, pages 118-125.
Crossref
Nagendra K. Chaturvedi, Timothy R. McGuire, Don W. Coulter, Ashima Shukla, Erin M. McIntyre, John Graham Sharp & Shantaram S. Joshi. (2016) Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecan. Oncotarget 7:12, pages 15215-15229.
Crossref
Yalan Bi, Yunxiao Meng, Huanwen Wu, Quancai Cui, Yufeng Luo & Xiaowei Xue. (2016) Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis. Journal of Surgical Oncology 113:2, pages 144-151.
Crossref
Mehrdad Nasrollahzadeh Sabet, Azadeh Rakhshan, Elham Erfani & Zahra Madjd. (2014) Co-Expression of Putative Cancer Stem Cell Markers, CD133 and Nestin, in Skin Tumors. Asian Pacific Journal of Cancer Prevention 15:19, pages 8161-8169.
Crossref
Nasser Rakhshani, Elham Kalantari, Hadi Bakhti, Masoud Reza Sohrabi & Mitra Mehrazma. (2014) Evaluation of HER-2/neu Overexpression in Gastric Carcinoma using a Tissue Microarray. Asian Pacific Journal of Cancer Prevention 15:18, pages 7597-7602.
Crossref
Maryam Monajemzadeh, Vahid Soleimani, Mohammad Vasei, Leili Koochakzadeh & Mojgan Karbakhsh. (2014) Expression and prognostic significance of Oct4 and Nanog in neuroblastoma. APMIS 122:9, pages 734-741.
Crossref
Ehsan Aali, Solmaz Mirzamohammadi, Habib Ghaznavi, Zahra Madjd, Bagher Larijani, Samira Rayegan & Ali M Sharifi. (2014) A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats. Journal of Diabetes & Metabolic Disorders 13:1.
Crossref
Elmira Gheytanchi, Mitra Mehrazma & Zahra Madjd. (2014) Expression of Ki-67, p53 and VEGF in Pediatric Neuroblastoma. Asian Pacific Journal of Cancer Prevention 15:7, pages 3065-3070.
Crossref
Hossein Keymoosi, Elmira Gheytanchi, Mojgan Asgari, Ahmad Shariftabrizi & Zahra Madjd. (2014) ALDH1 in Combination with CD44 as Putative Cancer Stem Cell Markers are Correlated with Poor Prognosis in Urothelial Carcinoma of the Urinary Bladder. Asian Pacific Journal of Cancer Prevention 15:5, pages 2013-2020.
Crossref
Zahra Madjd, Mohammad Esmaeil Akbari, Amir Hassan Zarnani, Maryam Khayamzadeh, Elham Kalantari & Nazanin Mojtabavi. (2014) Expression of EMSY, a Novel BRCA2-link Protein, is Associated with Lymph Node Metastasis and Increased Tumor Size in Breast Carcinomas. Asian Pacific Journal of Cancer Prevention 15:4, pages 1783-1789.
Crossref
Jaleh Taeb, Mojgan Asgari, Maryam Abolhasani, Mohammad M. Farajollahi & Zahra Madjd. (2014) Expression of prostate stem cell antigen (PSCA) in prostate cancer: A tissue microarray study of Iranian patients. Pathology - Research and Practice 210:1, pages 18-23.
Crossref
Juan Carlos Mellídez Barroso & Maria C. Santos. 2014. Stem Cells in Cancer: Should We Believe or Not?. Stem Cells in Cancer: Should We Believe or Not? 263 290 .
Monireh Mohsenzadegan, Zahra Madjd, Mojgan Asgari, Maryam Abolhasani, Mehdi Shekarabi, Jaleh Taeb & Ahmad Shariftabrizi. (2013) Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunology, Immunotherapy 62:10, pages 1609-1618.
Crossref
Jiang-jie DuanWen QiuSen-lin XuBin WangXian-zong YeYi-fang PingXia ZhangXiu-wu BianShi-cang Yu. (2013) Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done. Stem Cells and Development 22:16, pages 2221-2239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.